UnitedHealth Group Incorporated

Berkshire Hathaway Inc.

Shares of health insurance giant UnitedHealth Group lost about 60% of their value between April and August 2025. Falling financial indicators, change of CEOs (one was killed, the other resigned), investigation of suspicions of fraud against the background of the insurer's ambiguous reputation all converged at one point. And yet Warren Buffett spent $1.6 billion to buy UnitedHealth shares. Should we follow his example?

Old school: why Buffett and Soros bought UnitedHealth stock

The Oncology Institute, Inc.

Shares of The Oncology Institute (TOI), a small-cap medical practice management company <a href="https://theoncologyinstitute.com/">specializing</a>&nbsp;in community-based oncology practices, could more than double in the medium term, Noble Capital Markets&nbsp;<a href="https://www.channelchek.com/news-channel/the-oncology-institute-inc-toi-improving-oncology-treatment-while-cutting-costs">believes</a>. The company is expanding into new geographies and has flexibility to contract with more insurance plans, it argues.&nbsp;

Noble initiates on cancer care provider TOI with 'buy', sees triple-digit upside

Carlsmed

Shares of Carlsmed, a provider of specialized artificial intelligence-based equipment and software for personalized spine surgeries, have become available to investors on the Freedom customer trading system. The securities are listed under the ticker symbol CARL. They will appear on the Nasdaq exchange in a few hours;

Carlsmed IPO: Shares in Carlsmed, a pioneer in AI spine surgery, become available


Universal Health Services, Inc.

HCA Healthcare, Inc.

Tenet Healthcare Corporation

One of the affected sectors will be healthcare, but the bank's analysts have named a stock that is favored

Who will win and lose from the "big and beautiful" law: Morgan Stanley's forecast

Shares of biotech micro cap Equillium <a href="https://www.marketwatch.com/investing/stock/eq?utm_source=in_materials">soared</a> 33% yesterday, Thursday, February 6, although some of the gains have been lost before the opening bell today. The company <a href="https://www.equilliumbio.com/investors/press-releases/news-details/2025/Equillium-Announces-Positive-Data-from-Phase-2-Study-Evaluating-Itolizumab-in-Patients-with-Moderate-to-Severe-Ulcerative-Colitis/default.aspx?utm_source=in_materials">announced</a> that its drug for ulcerative colitis, which it is testing together with Indian pharmaceutical giant Biocon, has shown results that are no worse than the standard of care for the disease. The therapy is Equillium’s lead candidate to get to market.

Announced successful drug trials boost micro cap Equillium by 33%

Quotes on the small-cap telemedicine platform Teladoc Health <a href="https://finance.yahoo.com/quote/TDOC/?utm_source=in_materials">surged</a> almost 6% yesterday, Wednesday, February 5, before extending the gains in premarket trading today. The trigger was an announcement that the company had signed an agreement to acquire Catapult Health, which provides at-home diagnostic kits. The deal follows a challenging period that saw the market valuation of Teladoc shrink more than 18-fold from its pandemic peak.

Virtual healthcare provider Teladoc to acquire competitor; shares jump 6%

Shares of Viemed Healthcare, a company with a market capitalization of almost $355 million that provides in-home respiratory support, surged almost 16% in after-hours trading on Wednesday, November 6. The gains were attributable to third-quarter financial results, which featured record- and guidance-beating revenue.

#Healthcare: 7